Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27.

SAMPRE NUTRITIONS LIMITED CIN: L15499TG1991PLC013515 Date: 02 November 2026 BSE Limited 2nd Floor, New Trading Wing, Rotunda Building, P.J. Towers, Dalal Street, Fort, Mumbai - 400001, MH Subject: Intimation of Board Meeting Reference: BSE Symbol: SAMPRE; BSE Scrip Code: 530617 Sir / Ma’am, We wish to inform you that pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (“Listing Regulations”) and other applicable Regulations, a meeting of the Board of Directors of Sampre Nutritions Limited (“the Company”) is scheduled to be held on Friday, 06 November 2026, inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27. Kindly take the above information on record and acknowledge the receipt of the same. Thanking you. Sincerely, For Sampre Nutritions Limited Brahma Gurbani Managing Director (DIN: 00318180) Regd. Off & Works: Unit-1: Plot No. 133, I.E, Medchal - 501401, Telangana, India. Ph: +91-8418-222428 Unit-2: Plot No. 127, 128, Royes Building, I.E. Medchal, Malkajgiri - 501401, Telangana. e-mail: gurbani@gurbanigroup.in, bkgurbani@gurbanigroup.in, www.gurbanigroup.in